Showing results (341-350 of 909) with videos related to
Sort By:
Pageof 91
Circulation|November 15, 2021
Finerenone Reduces Risk of Incident Heart Failure in Patients With Chronic Kidney Disease and Type 2 Diabetes: Analyses From the FIGARO-DKD TrialGerasimos Filippatos, Stefan D Anker, Rajiv Agarwal, et al.JACC. Heart Failure|November 3, 2022
Finerenone and Heart Failure Outcomes by Kidney Function/Albuminuria in Chronic Kidney Disease and DiabetesGerasimos Filippatos, Stefan D Anker, Bertram Pitt, et al.Journal of the American College of Cardiology|June 6, 2020
Abnormalities of Potassium in Heart Failure: JACC State-of-the-Art ReviewJoão Pedro Ferreira, Javed Butler, Patrick Rossignol, et al.Lancet (London, England)|September 19, 2003
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trialJohn J V McMurray, Jan Ostergren, Karl Swedberg, et al.Lancet (London, England)|September 19, 2003
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved TrialSalim Yusuf, Marc A Pfeffer, Karl Swedberg, et al.Circulation|August 25, 2010
Effect of cardiac resynchronization therapy on reverse remodeling and relation to outcome: multicenter automatic defibrillator implantation trial: cardiac resynchronization therapyScott D Solomon, Elyse Foster, Mikhail Bourgoun, et al.Lancet (London, England)|September 19, 2003
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trialChristopher B Granger, John J V McMurray, Salim Yusuf, et al.American Heart Journal|August 23, 2006
Rationale and design of the Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT) trialAndrew G Bostom, Myra A Carpenter, John W Kusek, et al.American Journal of Hypertension|May 29, 2007
Augmentation index and central aortic stiffness in middle-aged to elderly individualsMitul Vyas, Joseph L Izzo, Yves Lacourcière, et al.Circulation|June 29, 2005
Effects of candesartan on the development of a new diagnosis of diabetes mellitus in patients with heart failureSalim Yusuf, Jan B Ostergren, Hertzel C Gerstein, et al.Pageof 91